Full-Time

Customer Service Representative

Confirmed live in the last 24 hours

Penumbra Inc

Penumbra Inc

1,001-5,000 employees

Develops medical devices for vascular conditions

No salary listed

Junior, Mid

No H1B Sponsorship

Turin, Metropolitan City of Turin, Italy

This is a hybrid position, indicating a mix of remote and in-office work.

Category
Customer Experience & Support
Customer Support
Required Skills
Sales
SAP Products
Customer Service
Requirements
  • Bachelor’s degree in Business, Marketing, or a related field preferred – an equivalent combination of education and relevant experience will also be considered
  • Minimum of 2 years’ experience in Customer Service, Sales, or another customer-focused role
  • Strong oral and written communication skills, with the ability to build positive customer relationships, especially over the phone
  • Proficiency in Microsoft Office (Outlook, Word, Excel, PowerPoint) and experience with SAP or other ERP systems
  • Advanced written and spoken English
Responsibilities
  • Respond to customer inquiries by processing orders accurately, efficiently, and with a customer-centric approach
  • Utilize company systems and processes (SAP) to enter sales orders, contovisione orders, and consignment replacements – ensuring inventory availability and setting up customized defaults tailored to each customer’s needs
  • Process Returned Merchandise Authorizations (RMAs) in alignment with company procedures, prioritizing timely and transparent communication
  • Register, track, and follow up on customer complaints, acting as a reliable partner in finding solutions
  • Build and maintain strong, trust-based customer relationships through excellent service and proactive support
  • Manage the Travel Stock program, ensuring full compliance with the Quality System and seamless coordination across teams
  • Maintain and update customer databases with care and precision, supporting data integrity and process efficiency
Desired Qualifications
  • Bachelor’s degree in Business, Marketing, or a related field preferred – an equivalent combination of education and relevant experience will also be considered

Penumbra Inc. specializes in creating medical devices for treating neurovascular and peripheral vascular conditions. Their products, such as the Penumbra System and Indigo System, are designed to assist healthcare professionals in addressing issues like stroke and other vascular diseases. These devices work by providing advanced tools for interventions in neurology and vascular surgery, helping to improve patient outcomes. Unlike many competitors, Penumbra focuses specifically on these specialized areas and invests heavily in research and development to enhance their offerings. The company's goal is to deliver high-quality medical devices that meet the needs of healthcare providers and improve the treatment of vascular conditions.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Alameda, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Increased AI adoption enhances precision in stroke detection, complementing Penumbra's devices.
  • Telemedicine rise creates opportunities for integrating products with digital health platforms.
  • Healthcare infrastructure expansion in emerging markets opens new distribution channels for Penumbra.

What critics are saying

  • Don Kassing's retirement may lead to a temporary gap in strategic guidance.
  • Italian government's payback provision indicates potential future financial liabilities.
  • Expansion plans in Costa Rica could face operational challenges or delays.

What makes Penumbra Inc unique

  • Penumbra specializes in innovative devices for neurovascular and peripheral vascular conditions.
  • The company offers a broad portfolio, including the Penumbra System and Indigo System.
  • Penumbra's products are used globally, enhancing its international market presence.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Parental Leave

Paid Vacation

Paid Sick Leave

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

-1%

1 year growth

0%

2 year growth

0%
Neuro News International
Apr 24th, 2025
Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements

Penumbra announces Red 72 Silver Label product featuring company's latest engineering enhancements.

PR Newswire
Apr 3rd, 2025
Penumbra, Inc. Schedules First Quarter 2025 Earnings Release And Conference Call For April 23, 2025

ALAMEDA, Calif., April 3, 2025 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2025 after market close on Wednesday, April 23, 2025 at 4:30 PM Eastern Time. A press release with first quarter 2025 financial results will be issued after market close that day.Webcast & Conference Call InformationThe conference call can be accessed live over the phone by dialing (888) 596-4144 (conference id: 6572573), or the webcast can be accessed on the "Events and Presentations" section under the "Investors" tab of the Company's website at www.penumbrainc.com. The webcast will be available on the Company's website for at least two weeks following the completion of the call.About PenumbraPenumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life

Penumbrainc
Mar 17th, 2025
Latest Data on Penumbra's CAVT Technology to Be Presented at SIR 2025: STRIDE, STRIKE-PE, and More

Latest data on Penumbra's CAVT technology to be presented at SIR 2025: STRIDE, STRIKE-PE, and more.

Neuro News International
Feb 28th, 2025
Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access

Penumbra launches Access25 delivery microcatheter designed for brain aneurysm access.

Penumbrainc
Feb 27th, 2025
Penumbra Launches ACCESS25[TM] Delivery Microcatheter Designed for Aneurysm Access and Delivery of Elevated Clinical Benefits

Penumbra recently launched the ACCESS25 Delivery Microcatheter, a single lumen medical device designed to aid physicians in accessing the neurovasculature for the delivery of Penumbra's advanced .020" coil platform.